Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Cash flows from operating activities:
Net loss	$ (5,195,065)	$ (4,440,566)	$ (14,094,527)	$ (11,260,662)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization			11,505,709	10,245,789
Amortization of debt issuance costs	207,942	216,022	591,310	540,404
Stock based compensation expense related to issuance of restricted stock			15,010
Increase (decrease) in cash, cash equivalents, and restricted cash from changes in assets and liabilities:
Other assets			(150,001)	(823,490)
Accounts payable and accrued liabilities			1,882,431	2,758,122
Due to affiliates			2,921,658	534,658
Net cash provided by operating activities			2,671,590	1,994,821
Cash flows from investing activities:
Purchase of real estate facilities				(170,123,441)
Additions to real estate facilities			(1,323,146)	(303,285)
Additions to construction in process			(8,061,552)
Investment in company owned life insurance			(420,243)
Settlement of company owned life insurance			420,243
Net cash used in investing activities			(9,384,698)	(170,426,726)
Cash flows from financing activities:
Proceeds from issuance of non-revolving mortgage debt				110,105,000
Proceeds from issuance of KeyBank Bridge Loans			7,349,284	51,500,000
Principal payments of KeyBank Bridge Loans			(2,598,245)	(10,148,136)
Debt issuance costs			(223,018)	(2,349,937)
Issuance of preferred equity in our Operating Partnership				6,301,116
Gross proceeds from issuance of common stock			6,817,149	16,798,588
Redemptions of common stock			(178,960)	(1,535,689)
Offering costs			(530,060)	(369,831)
Distributions paid to common stockholders			(3,570,827)	(2,989,432)
Distributions paid to Operating Partnership unitholders			(11,847)	(9,337)
Net cash provided by financing activities			7,053,476	167,302,342
Net change in cash, cash equivalents, and restricted cash			340,368	(1,129,563)
Cash, cash equivalents, and restricted cash, beginning of period			11,272,611	10,371,998	$ 10,371,998
Cash, cash equivalents, and restricted cash, end of period	$ 11,612,979	$ 9,242,435	11,612,979	9,242,435	$ 11,272,611
Supplemental disclosures and non-cash transactions:
Cash paid for interest			7,670,411	3,898,287
Interest capitalized			280,679
Additions to debt issuance costs included in accounts payable and accrued liabilities				16,095
Deposits applied to purchase of real estate				1,000,000
Acquisition costs included in due to affiliates				1,980,000
Additions to real estate and construction in process in accounts payable and accrued liabilities			1,370,493
Proceeds from issuance of common stock previously in accounts payable and accrued liabilities			48,900
Offering costs included in accounts payable and accrued liabilities or due to affiliates			992,905	588,161
Non-cash preferred equity issuance in our Operating Partnership				63,011
Distributions payable			1,341,889	653,431
Redemptions of common stock included in accounts payable and accrued liabilities			94,284
Issuance of shares pursuant to distribution reinvestment plan			$ 1,749,225	1,783,686
Public offering costs previously included in other assets				$ 722,840